Crossref journal-article
American Society for Microbiology
Antimicrobial Agents and Chemotherapy (235)
Abstract

ABSTRACT Some strains of Pseudomonas aeruginosa produce R-type pyocins, which are high-molecular-weight phage tail-like protein complexes that have bactericidal activity against other Pseudomonas strains. These particles recognize and bind to bacterial surface structures via tail fibers, their primary spectrum determinant. R-type pyocins kill the cell by contracting a sheath-like structure and inserting their hollow core through the cell envelope, resulting in dissipation of the cellular membrane potential. We have retargeted an R-type pyocin to Escherichia coli O157:H7 by fusing a tail spike protein from an O157-specific phage, φV10, to the pyocin tail fiber. The φV10 tail spike protein recognizes and degrades the O157 lipopolysaccharide. This engineered pyocin, termed AVR2-V10, is sensitive and specific, killing 100% of diverse E. coli O157:H7 isolates but no other serotypes tested. AVR2-V10 can kill E. coli O157:H7 on beef surfaces, making it a candidate agent for the elimination of this pathogen from food products. All rare AVR2-V10-resistant mutants isolated and examined have lost the ability to produce the O157 antigen and are expected to have compromised virulence. In addition, E. coli O157:H7 exposed to and killed by AVR2-V10 do not release Shiga toxin, as is often the case with many antibiotics, suggesting potential therapeutic applications. The demonstration that a novel R-type pyocin can be created in the laboratory by fusing a catalytic tail spike from the family Podoviridae to a tail fiber of a member of the family Myoviridae is evidence that the plasticity observed among bacteriophage tail genes can, with modern molecular techniques, be exploited to produce nonnatural, targeted antimicrobial agents.

Bibliography

Scholl, D., Cooley, M., Williams, S. R., Gebhart, D., Martin, D., Bates, A., & Mandrell, R. (2009). An Engineered R-Type Pyocin Is a Highly Specific and Sensitive Bactericidal Agent for the Food-Borne Pathogen Escherichia coli O157:H7. Antimicrobial Agents and Chemotherapy, 53(7), 3074–3080.

Authors 7
  1. Dean Scholl (first)
  2. Mike Cooley (additional)
  3. Steve R. Williams (additional)
  4. Dana Gebhart (additional)
  5. David Martin (additional)
  6. Anna Bates (additional)
  7. Robert Mandrell (additional)
References 33 Referenced 111
  1. Ahn, C. K., E. Klein, and P. I. Tarr. 2008. Isolation of patients acutely infected with Escherichia coli O157:H7: low tech, highly effective prevention of hemolytic uremic syndrome. Clin. Infect. Dis.46:1197-1199. (10.1086/587664) / Clin. Infect. Dis. (2008)
  2. Cooley, M., D. Carychao, L. Crawford-Miksza, M. T. Jay, C. Myers, C. Rose, C. Keys, J. Farrar, and R. E. Mandrell. 2008. Incidence and tracking of E. coli O157:H7 in a major produce production region in California. PLoS One2:e1159. / PLoS One (2008)
  3. 10.1128/jb.177.14.4121-4130.1995
  4. 10.1093/infdis/129.4.470
  5. 10.1128/IAI.01342-06
  6. 10.1016/S0022-2836(65)80107-3
  7. 10.2323/jgam.16.3_205
  8. 10.1038/nature04487
  9. 10.1093/oxfordjournals.jbchem.a127839
  10. 10.1093/oxfordjournals.jbchem.a127841
  11. 10.1128/JB.00657-07
  12. Kropinski, A. M., I. V. Kovalyova, S. J. Billington, A. N. Patrick, B. D. Butts, J. A. Guichard, T. J. Pitcher, C. C. Guthrie, A. D. Sydlaske, L. M. Barnhill, K. A. Havens, K. R. Day, D. R. Falk, and M. R. McConnell. 2007. The genome of epsilon15, a serotype-converting, group E1 Salmonella enterica-specific bacteriophage. Virology369:234-244. (10.1016/j.virol.2007.07.027) / Virology (2007)
  13. 10.1042/bj3090543
  14. Machida, Y., K. Miyake, K. Hattori, S. Yamamoto, M. Kawase, and S. Iijima. 2000. Structure and function of a novel coliphage-associated sialidase. FEMS Microbiol. Lett.182:333-337. (10.1111/j.1574-6968.2000.tb08917.x) / FEMS Microbiol. Lett. (2000)
  15. 10.1128/jb.175.5.1257-1263.1993
  16. 10.1128/am.23.1.164-165.1972
  17. 10.1016/S0300-9084(02)01422-0
  18. 10.1046/j.1365-2958.2000.02135.x
  19. 10.3201/eid1104.040739
  20. 10.1128/JB.187.24.8499-8503.2005
  21. Scholl, D., and C. Merril. 2005. Polysaccharide-degrading phages, p. 400-414. InPhages: their role in bacterial pathogenesis and biotechnology. ASM Press, Washington, DC. / Phages: their role in bacterial pathogenesis and biotechnology (2005)
  22. 10.1128/AAC.01479-07
  23. 10.1006/jsbi.1998.3974
  24. 10.1128/jvi.44.2.692-695.1982
  25. 10.1007/BF00325898
  26. 10.4315/0362-028X-67.10.2342
  27. 10.1016/0022-2836(88)90246-X
  28. 10.1128/AEM.67.12.5634-5642.2001
  29. 10.1128/jb.157.2.632-636.1984
  30. 10.1111/j.1574-6968.2000.tb08909.x
  31. 10.1128/JVI.01641-07
  32. 10.1128/AEM.00141-08
  33. 10.1056/NEJM200006293422601
Dates
Type When
Created 16 years, 4 months ago (April 6, 2009, 9:07 p.m.)
Deposited 3 years, 6 months ago (Feb. 21, 2022, 3:09 p.m.)
Indexed 4 weeks, 1 day ago (July 30, 2025, 11:24 a.m.)
Issued 16 years, 1 month ago (July 1, 2009)
Published 16 years, 1 month ago (July 1, 2009)
Published Print 16 years, 1 month ago (July 1, 2009)
Funders 0

None

@article{Scholl_2009, title={An Engineered R-Type Pyocin Is a Highly Specific and Sensitive Bactericidal Agent for the Food-Borne Pathogen Escherichia coli O157:H7}, volume={53}, ISSN={1098-6596}, url={http://dx.doi.org/10.1128/aac.01660-08}, DOI={10.1128/aac.01660-08}, number={7}, journal={Antimicrobial Agents and Chemotherapy}, publisher={American Society for Microbiology}, author={Scholl, Dean and Cooley, Mike and Williams, Steve R. and Gebhart, Dana and Martin, David and Bates, Anna and Mandrell, Robert}, year={2009}, month=jul, pages={3074–3080} }